DJIA 17,440.59 -127.94 -0.73%
NASDAQ 5,039.78 -48.85 -0.96%
S&P 500 2,067.64 -12.01 -0.58%
market minute promo

United Therapeutics Corp (NASDAQ: UTHR)

165.55 -3.73 (-2.20%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

UTHR $165.55 -2.20%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $168.68
Previous Close $169.28
Daily Range $164.07 - $169.39
52-Week Range $86.04 - $190.29
Market Cap $7.7B
P/E Ratio 48.50
Dividend (Yield) $0.00 (0.0%)
Volume 808,056
Average Daily Volume 554,183
Current FY EPS $7.09




Drug Makers

United Therapeutics Corp (UTHR) Description

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases. Website:

News & Commentary

Maverick Capital: Here's What This Hedge Fund Company Has Been Buying

Keeping up with Maverick Capital and other big investors can yield some insights and investment ideas.

Commit To Buy United Therapeutics Corp At $125, Earn 8% Using Options

Lessons Learned: Time To Simplify The Well-Valued Growth Portfolio

United Therapeutics Appears Undervalued

United Therapeutics Faces Patent Challenge for Tyvaso - Analyst Blog

United Therapeutics Corporation Receives Paragraph IV Notice Letter for Tyvaso

Top Mutual Funds Add To Medical Holdings

The Growth Portfolio Keeps On Growing

United Therapeutics Corporation - ZER Reports

United Therapeutics Corporation - ZER Reports

The Highest Paid CEOs in Biotech

These highest paid CEOs in biotech brought in a minimum of $24 million in compensation in 2014. Find out what makes these leaders so special, and whether or not their exorbitant pay packages are sustainable.

See More UTHR News...

UTHR's Top Competitors

UTHR $165.55 (-2.20%)
Current stock: UTHR
AMGN $165.54 (4.38%)
Current stock: AMGN
GILD $110.54 (-2.03%)
Current stock: GILD
BIIB $309.43 (3.13%)
Current stock: BIIB